Jeffrey A Dvergsten
Overview
Explore the profile of Jeffrey A Dvergsten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pinotti C, Cannon L, Dvergsten J, Wu E
Front Med (Lausanne)
. 2023 Mar;
10:1155839.
PMID: 36936211
Calcinosis, or the deposition of insoluble calcium salts in the skin, subcutaneous tissue, fascia, tendons, and muscles, is a feared complication of juvenile dermatomyositis. Calcinosis is estimated to affect up...
2.
Stingl C, Dvergsten J, Eng S, Yeung R, Fritzler M, Mason T, et al.
ACR Open Rheumatol
. 2022 May;
4(8):671-681.
PMID: 35616642
Objective: The study objective was to identify differences in gene expression between treatment responders (TRs) and treatment non-responders (TNRs) diagnosed with juvenile dermatomyositis (JDM). Methods: Gene expression analyses were performed...
3.
Dvergsten J, Reed A, Landerman L, Pisetsky D, Ilkayeva O, Huffman K
Rheumatology (Oxford)
. 2021 Jun;
61(4):1699-1708.
PMID: 34185053
Objectives: To perform an exploratory study to identify a JDM serum metabolic profile that differs from healthy controls (HCs) and responds to immunosuppressive treatment. Methods: Blood was collected from 9...
4.
Liu K, Tomlinson G, Reed A, Huber A, Saarela O, Bout-Tabaku S, et al.
J Rheumatol
. 2020 Apr;
48(1):114-122.
PMID: 32238513
Objectives: To determine the feasibility of comparing the Childhood Arthritis and Rheumatology ResearchAlliance (CARRA) consensus treatment plans (CTP) in treating moderate new-onset juvenile dermatomyositis (JDM) using the CARRA registry, and...
5.
Ferguson I, Griffin P, Michel J, Yano H, Gaffen S, Mueller R, et al.
Front Immunol
. 2018 Aug;
9:1802.
PMID: 30127787
T cells are considered autoimmune effectors in juvenile idiopathic arthritis (JIA), but the antigenic cause of arthritis remains elusive. Since T cells comprise a significant proportion of joint-infiltrating cells, we...
6.
Zhao Y, Wu E, Oliver M, Cooper A, Basiaga M, Vora S, et al.
Arthritis Care Res (Hoboken)
. 2017 Nov;
70(8):1228-1237.
PMID: 29112802
Objective: To develop standardized treatment regimens for chronic nonbacterial osteomyelitis (CNO), also known as chronic recurrent multifocal osteomyelitis (CRMO), to enable comparative effectiveness treatment studies. Methods: Virtual and face-to-face discussions...
7.
Kalampokis I, Venturi G, Poe J, Dvergsten J, Sleasman J, Tedder T
Arthritis Rheumatol
. 2016 Jul;
69(1):225-238.
PMID: 27429419
Objective: Regulatory B cells that inhibit immune responses through interleukin-10 (IL-10) secretion (B10 cells) have been characterized in adult subjects with autoimmune disease. The aim of this study was to...
8.
Dvergsten J, Mueller R, Griffin P, Abedin S, Pishko A, Michel J, et al.
Arthritis Rheum
. 2013 May;
65(8):2201-10.
PMID: 23686519
Objective: CD8+ T cells lacking CD28 were originally reported to be a characteristic feature of juvenile idiopathic arthritis (JIA), but the relevance of these unusual cells to this disease remains...
9.
Vallejo A, Mueller R, Hamel Jr D, Way A, Dvergsten J, Griffin P, et al.
Ageing Res Rev
. 2010 Oct;
10(3):354-61.
PMID: 20932941
As the repertoire of αβT cell receptors (TCR) contracts with advancing age, there is an associated age-dependent accumulation of oligoclonal T cells expressing of a variety of receptors (NKR), normally...